HEC Management GP LLC is Director at EAGLE PHARMACEUTICALS, INC. (EGRX). They have made 10 open-market trades across 4 companies since 2018, most recently 2021-11-23.
CIK 0001700567
7 open-market purchases totalling $27.5M since 2018, against 3 sales. Across 7 scored buys the stock is down 3.2% at ninety days, and 8.1 points behind the S&P over the same stretch.
7 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 14% | 14% | 14% |
| Avg Move | +1.2% | -0.7% | -3.2% |
| Alpha | +2.1% | -2.3% | -8.1% |
| Scored | 7 | 7 | 7 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TALK | BUY | 2021-11-23 | 2021-11-24 | $2.08 | $2.1M | -2.7% | -9.5% | -37.3% |
| EGRX | SELL | 2019-10-21 | 2019-10-23 | $62.64 | $1.3M | +1.7% | -11.3% | -6.0% |
| USAT | BUY | 2019-10-16 | 2019-10-16 | $7.26 | $1.2M | +0.0% | +0.0% | +0.0% |
| USAT | BUY | 2019-10-14 | 2019-10-16 | $6.70 | $536K | +0.0% | +0.0% | +0.0% |
| EGRX | SELL | 2019-10-07 | 2019-10-09 | $60.09 | $776K | +4.9% | +6.2% | -3.5% |
| USAT | BUY | 2019-09-26 | 2019-09-26 | $4.87 | $2.9M | +0.0% | +0.0% | +0.0% |
| USAT | BUY | 2019-09-25 | 2019-09-26 | $4.43 | $5.2M | +0.0% | +0.0% | +0.0% |
| USAT | BUY | 2019-09-23 | 2019-09-23 | $4.46 | $639K | -2.0% | -2.0% | -2.0% |
| EGRX | SELL | 2019-09-11 | 2019-09-13 | $60.06 | $146K | -3.5% | +6.0% | +3.2% |
| CATM | BUY | 2018-02-21 | 2018-02-23 | $23.32 | $14.9M | +13.2% | +6.7% | +17.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.